Trial intelligence / Profile preview

Comparison of oral dydrogesterone vs intramuscular progesterone on endometrial receptivity

ChiCTR2100042318Phase 4Recruiting

Sponsor
Zhejiang Provincial People's Hospital
Start
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of dydrogesterone and progesterone (2 arms), sponsored by Zhejiang Provincial People's Hospital. Primary endpoints: Endometrial pinocytosis count and distribution and Pinocytosis index. Started Jan 2021; status: recruiting.

02

Drugs

dydrogesteroneprogesterone

Beyond the preview

Go deeper on ChiCTR2100042318.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100042318.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call